Menzaghi Frederique Ph.D.

Avg. Two Year Performance

No purchase track record

3% Avg. Sale Return

2% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	2%	8%	16%	20%	3%
Sale Success Rate	12 of 31	16 of 31	18 of 31	15 of 31	11 of 31

Cara Therapeutics, Inc.

Drugs » Biotechnology

Chief Scientific Off,SVP-R&D:

Holdings: 167.25K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--